Nurokript XT Tablet is a pharmaceutical formulation combining L-Methyl Folate (1mg), Methylcobalamin (1500mcg), and Pyridoxal-5-phosphate (0.5mg), designed to support neurological health and metabolic functions. L-Methyl Folate, the bioactive form of folate, plays a critical role in methylation processes, DNA synthesis, and neurotransmitter regulation, making it essential in managing conditions associated with folate deficiency and certain neuropsychiatric disorders. Methylcobalamin, an active form of vitamin B12, is vital for maintaining myelin sheath integrity, promoting nerve regeneration, and supporting hematopoiesis. Pyridoxal-5-phosphate, the active form of vitamin B6, functions as a coenzyme in amino acid metabolism and neurotransmitter synthesis, contributing to optimal nervous system function. The synergistic combination in Nurokript XT enhances neuroprotection, supports cognitive function, and aids in the management of peripheral neuropathies, depression, and other neurological impairments. This tablet is indicated for patients with vitamin B deficiencies, diabetic neuropathy, and those requiring adjunctive therapy for neurodegenerative conditions. Nurokript XT should be administered under medical supervision, with dosage tailored to individual patient needs, and is generally well-tolerated with minimal adverse effects. Regular monitoring of vitamin levels and clinical response is recommended to ensure therapeutic efficacy and safety.